New Ray Medicine International Holding Ltd. logo

New Ray Medicine International Holding Ltd.

6108.HK

HKSEHealthcareMedical - Pharmaceuticals

最新資料

HK$0.225

+HK$0.016 · +7.66%

8月21日 下午1:10 HKT

6108.HK公司概覽

盤中時間採用HKT。市場資料可能有所延遲。

公司概況

公司網站

New Ray Medicine International Holding Ltd. is an investment company, which engages in the distribution and trading of pharmaceutical products. It operates through the following business segments: Injection Drugs; Capsule and Granule Drugs; Tablet Drugs; Marketing and Promotion Services; and Others. The Injection Drugs segment includes the trading of injection drugs. The Capsule and Granule Drugs segment relates to the selling of capsule and granule drugs. The Tablet Drugs segment comprises tablet drugs. The Marketing and Promotion Services segment focuses in the marketing and promotion of services of drugs. The Others segment trades miscellaneous types of goods and drugs, other than injection drugs, capsule and granule drugs, and tablet drugs. The company was founded on August 9, 2012 and is headquartered in Hangzhou, China.

產業
Medical - Pharmaceuticals
部門
Healthcare
總部
CN
執行長
Qiuqin Wang
上市以來
2013年10月28日
僱員
31

市場位置

52週區間

目前HK$0.225,

開盤價
HK$0.225
前收盤價
HK$0.209
成交量
7.2萬
0.79× 平均值
平均成交量
9.13萬
日均成交量
市值
4513.88萬 HKD
貝塔
-3.94
市場參考 1
50天平均值
HK$0.2061
高於平均水平+9.15%
200天平均值
HK$0.2284
低於平均水平-1.49%

6108.HK同業公司

繼續GoAI的研究

在 GoAI 中研究6108.HK

research.disclaimer